Comment
. 2005 Aug 16;173(4):344; author reply 344-5.
doi: 10.1503/cmaj.1050034.
Effect of thiazolidinediones on lipid profile
- PMID: 16103495
- PMCID: PMC1188204
- DOI: 10.1503/cmaj.1050034
Item in Clipboard
Comment
Effect of thiazolidinediones on lipid profile
CMAJ.
.
No abstract available
Comment on
-
Oral antihyperglycemic therapy for type 2 diabetes mellitus.CMAJ. 2005 Jan 18;172(2):213-26. doi: 10.1503/cmaj.1031414. CMAJ. 2005. PMID: 15655244 Free PMC article. Review.
Similar articles
-
Thiazolidinediones.N Engl J Med. 2005 Jan 13;352(2):205-7; author reply 205-7. doi: 10.1056/NEJM200501133520222. N Engl J Med. 2005. PMID: 15647589 No abstract available.
-
Thiazolidinediones and blood lipids in type 2 diabetes.Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1744-9. doi: 10.1161/01.ATV.0000090521.25968.4D. Epub 2003 Aug 7. Arterioscler Thromb Vasc Biol. 2003. PMID: 12907465
-
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.Adv Ther. 2012 Sep;29(9):736-46. doi: 10.1007/s12325-012-0045-5. Epub 2012 Aug 24. Adv Ther. 2012. PMID: 22923161 Review.
-
Effects of pioglitazone on lipid and lipoprotein metabolism.Diabetes Obes Metab. 2007 Sep;9(5):640-7. doi: 10.1111/j.1463-1326.2007.00715.x. Diabetes Obes Metab. 2007. PMID: 17697057 Review.
-
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.Am J Cardiol. 2006 Mar 1;97(5):646-50. doi: 10.1016/j.amjcard.2005.09.101. Epub 2006 Jan 9. Am J Cardiol. 2006. PMID: 16490430 Clinical Trial.
References
-
- Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coron Artery Dis 2001;12:413-23. - PubMed
-
- Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Am J Med 2001;111:10-7. - PubMed
-
- Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy. Int J Clin Pract 2002;56:251-7. - PubMed
-
- Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI; Rosiglitazone Clinical Trials Study Group. Rosiglitazone monotherapy is effective in patients with type 2 diabetes [published errata appear in J Clin Endocrinol Metab 2001;86:1659, 2002;87:iv]. J Clin EndocrinolMetab 2001;86:280-8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
